Learn about the promises and challenges of advanced therapies throughout the drug life cycle. How do advanced therapies differ from conventional molecular approaches? What is needed to get advanced therapies from bench to bedside? In this course we will cover these topics in an interactive manner combining lectures, discussions, and hands-on workshops. All steps in the drug life cycle will be discussed.
In this ONLINE course we will discuss all aspects of the drug life cycle and how these aspects influence the medicines of the future.
We start with an overview of current and coming cell and gene therapies. Then we discuss with a panel of experts from industry, clinic, academia, regulation and paitent federations the challenges at hand.
The second day we will work on your knowledge of cell and molecular biology. Day three and four are focused on cell and gene therapy and include a practical experiment. On the final day, the attandants present their group assignments and we finish the course with a broader overview of posiible immunotherapies.
Please refer to the FMF website for more information, or contact us at firstname.lastname@example.org.
A flyer will be posted shortly.
The course is organised by the course director, dr. Ed Moret and several Future Medicines Fellows, a group of PhD students. Each day is hosted by a staff member of the Utrecht Institute for Pharmaceutical Sciences: prof. Bert Leufkens, dr. Manoe Janssen, dr. Massimiliano Caiazzo, prof. Enrico Mastrobattista and prof. Aletta Kraneveld.
Advanced master students, PhDs or professionals with a background in biology, pharmacy or other relevant field.
After this course the attendants will know exactly which cell and gene therapies are on the market. Furthermore, they will know which therapies are in the pipeline, and which technical, regulatory and financial hurdles have to be removed to clear this pipeline.
Due to the online nature of this course, a 50% discount on the course fee is applicable (400 euro).
Attendees from Utrecht University can apply for 50% discount on the course fee (200 euro).
PhD and MSc students from Utrecht University can apply for a 100% discount on the course fee (0 euro). We expect them to present a poster and to attend all course parts.
The course can be combined with the course Pharmaceutical Policy Analysis - M07. When combined with this course, the discount will be € 200.00 per course.
Housing through: Utrecht Summer School.
For this course you are required to upload the following documents when applying: